Integrative Medicine Dallas5330 Alpha Road, Suite 100 Dallas TX 75420

BRCATrue (Pathway Genomics) Dallas

BRCATrue – Among women, breast cancer is the second leading cause of cancer death. One in eight women will be affected by breast cancer in their lifetime.

Pathway Genomics’ BRCATrueTM is a next-generation sequencing test that searches for mutations in BRCA1 andBRCA2 genes. Having mutations in either the BRCA1 or theBRCA2 gene significantly increases a patient’s risk for breast, ovarian and other types of cancer.

The test is best suited for individuals with either a history of early onset breast or ovarian cancer or a strong family history of breast and/or ovarian cancer. Individuals with the following medical or family history factors should consider testing for mutations in BRCA1/2:

  • Early onset breast cancer (under 50 years of age)
  • Bilateral or multiple breast cancers
  • Diagnosed with both breast and ovarian cancer
  • Family history of breast and/or ovarian cancer
  • Two or moreBRCA1 or BRCA2-related cancers in a single family member
  • Male breast cancer within family
  • Ashkenazi Jewish ethnic background

Why Do BRCA Testing?

  • Guide decisions on prevention strategies (e.g. chemoprevention, prophylactic surgery)
  • Increase surveillance for breast cancer
  • Inform treatment decisions
  • Identify family members at increased risk

Contact Us Today!

I agree to the Terms of Use

Integrative Medicine Dallas
5330 Alpha Road, Suite 100
Dallas, TX 75420
Phone: 214-205-0012
Get Directions